US 6251396
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
expired A61KA61K38/00A61P
Quick answer
US patent 6251396 (Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein) held by Neurocrine Biosciences, Inc. expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P25/00, A61P25/28